Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus

Tissue Antigens

Volumn 49, Issue 6, 1997, Pages 635-639

  Eskdale, J ^a   Wordsworth, P ^b   Bowman, S ^b   Field, M ^a   Gallagher, G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

IL 10; Polymorphism; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 10;

ANTIBODY PRODUCTION; ARTICLE; CAUCASIAN; CONTROLLED STUDY; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030919267     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02812.x     Document Type: Article

References (15)

1. Malefyt RD, Abrams J, Bennet B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991: 174: 1209-1220.
2. Burdin N, Peronne C, Banchereau J, Rousset F. Epstein-Barr virus induces B-lymphocytes to produce human interleukin-10. J Exp Med 1993: 177: 295-304.
3. Rousset F, Garcia E, Defrance T et al. IL-10 is a potent growth and differentiation factor for human B-cells. Proc Natl Acad Sci U S A 1992: 89: 1890-1893.
4. Llorente L, Richaud-Patin Y, Fior R et al. In vivo production of interleukin-10 by non-T-cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus. Arthritis Rheum 1994: 37: 1647-1655.
5. Llorente L, Zou W, Levy Y et al. Role of interleukin-10 in the B-lymohocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995: 181: 839-844.
6. Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 1996: 39: 379-385.
7. Eskdale J, Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995: 42: 444-445.
8. Kube D, Platzer C, von Knethen A et al. Isolation of the human interleukin 10 promoter. Characterisation of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995: 7: 1-7.
9. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL-10 gene. Immunogenetics (in press).
10. Tan EM, Cohen AS, Freis JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982: 25: 1271-1277.
11. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995: 59: 97-105.
12. Everitt BS. The analysis of observational studies. In: Everitt BS, ed. Statistical methods for medical investigators. 2nd edn. London: Edward Arnold, 1993: 199-203.
13. Itoh K, Hirohata S. The role of IL-10 in human B-cell activation, proliferation and differentiation. J Immunol 1995: 154: 4341-4350.
14. Levy Y, Brouet J-C. Interleukin-10 prevents spontaneous cell death of germinal centre B-cells by induction of the Bcl-2 protein. J Clin Invest 1994: 93: 424-428.
15. Venables PJW, Eyi T, Woodrow DF, Moss J, Maini RN. Relationship of precipitating antibodies to soluble cellular antigens and histologically defined renal lesions in systemic lupus erythematosus. Ann Rheum Dis 1983: 43: 17-22.